Fezol Tablet 2.5 mg contains Letrozole, a potent aromatase inhibitor widely used in the management of hormone-sensitive conditions, particularly in women. Letrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogen. By reducing estrogen levels, Fezol Tablet helps regulate hormonal imbalances, making it effective for conditions where estrogen promotes disease progression or interferes with fertility.

Fezol Tablet is most commonly prescribed for the treatment of certain types of breast cancer in postmenopausal women, as well as for ovulation induction in women with infertility related to anovulation, such as in polycystic ovary syndrome (PCOS). It helps stimulate ovulation by lowering estrogen levels, thereby promoting the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Fezol Tablet 2.5 mg is indicated for:

• Hormone receptor-positive breast cancer in postmenopausal women, either as adjuvant therapy or in advanced/metastatic cases

• Ovulation induction in women with infertility caused by anovulation or irregular menstrual cycles

• Part of fertility treatment protocols in women undergoing assisted reproductive techniques (ART)

• Management of estrogen-dependent disorders under medical supervision

Mechanism of Action

• Aromatase inhibition: Letrozole selectively inhibits the aromatase enzyme, which reduces estrogen production in peripheral tissues.

• Hormonal regulation for ovulation: Reduced estrogen levels lead to increased FSH secretion from the pituitary gland, promoting follicular development and ovulation in women with fertility issues.

• Anti-proliferative effect in cancer: By lowering circulating estrogen, Fezol Tablet decreases the growth stimulus for estrogen receptor-positive breast cancer cells, slowing disease progression.

Dosage and Administration

Dosage varies depending on the condition being treated and should be individualized by a healthcare professional:

• For ovulation induction: 2.5 mg orally once daily for 5 consecutive days, usually starting on day 2–5 of the menstrual cycle

• For breast cancer: Dose and duration depend on the treatment regimen prescribed by an oncologist, typically 2.5 mg once daily

• Tablets should be swallowed whole with water and can be taken with or without food

• Adherence to the prescribed schedule is essential for optimal results

Benefits and Features

• Effective for ovulation induction and fertility management

• Reduces estrogen-driven proliferation in hormone-sensitive breast cancer

• Convenient oral tablet form for easy administration

• Clinically proven efficacy in both reproductive and oncological settings

• Minimizes risk of multiple ovulations compared to other ovulation induction therapies

Side Effects

Fezol Tablet is generally well tolerated, but some patients may experience:

• Hot flashes or mild menopausal-like symptoms

• Fatigue or dizziness

• Headache or nausea

• Joint or muscle pain

• Rarely, mood changes or bone density reduction with long-term use

Patients should consult a healthcare provider if severe or persistent side effects occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not recommended for use in premenopausal women for breast cancer treatment without supervision

• Contraindicated in pregnant or breastfeeding women

• Use with caution in patients with liver impairment

• Regular monitoring may be required during long-term therapy, especially for bone health

Storage Conditions

Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Fezol Tablet 2.5 mg is a safe, effective, and clinically proven solution for managing hormone-sensitive breast cancer and promoting ovulation in women with infertility under medical supervision.